All Posts: News Release
-
Howard and Georgetown Universities To Launch Joint Medical Humanities Center Funded by Mellon Foundation Grant
WASHINGTON (January 19, 2023) — The Mellon Foundation has awarded a 3.5 year, $3 million grant to support a collaboration between Georgetown University and Howard University in the establishment of a center for medical humanities. The Georgetown-Howard Center for Medical Humanities and Health Justice will focus on reducing health disparities in Washington through leveraging methods […]
Category: News Release
-
Drug Found to be Effective in Difficult to Treat Autoimmune Blood Disorder
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.
Category: News Release
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of dying from the disease in women who are at high risk.
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast cancer in older women.
Category: News Release
-
Mindfulness-Based Stress Reduction is as Effective as an Antidepressant Drug for Treating Anxiety Disorders
A guided mindfulness-based stress reduction program was as effective as use of the gold-standard drug — the common antidepressant escitalopram — for patients with anxiety disorders, according to results of a first-of-its-kind, randomized clinical trial led by researchers at Georgetown University Medical Center.
Category: News Release
-
BellRinger, Georgetown Lombardi Comprehensive Cancer Center’s Inaugural Bike Ride to End Cancer, Commences Saturday
Category: News Release
-
After Stroke in an Infant’s Brain, Right Side of Brain Compensates for Loss of Language in Left Side
As Children with Left-hemisphere Strokes Grow Up, Ability to Understand Language Shifts to Right side. WASHINGTON (October 10, 2022) — A clinical study conducted by researchers at Georgetown University Medical Center found that, for children who had a major stroke to the left hemisphere of their brain within days of their birth, the infant’s brain […]
Category: News Release
-
The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology
Category: News Release
-
Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors
Category: News Release
-
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
Category: News Release